GLENMEDE TRUST CO NA - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 222 filers reported holding TRANSMEDICS GROUP INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q2 2023$292,8470.0%3,8670.0%0.00%0.0%
Q1 2023$292,847
-34.6%
3,867
-72.9%
0.00%
-33.3%
Q2 2022$448,000
-24.2%
14,249
-35.1%
0.00%0.0%
Q1 2022$591,000
+43.4%
21,955
+2.1%
0.00%
+50.0%
Q4 2021$412,000
-11.2%
21,505
+53.3%
0.00%0.0%
Q3 2021$464,00014,0260.00%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q3 2023
NameSharesValueWeighting ↓
Roubaix Capital, LLC 264,438$5,027,0004.84%
Abrams Capital Management 3,499,859$66,532,0002.07%
Sandhill Capital Partners LLC 736,175$13,995,0001.55%
EMERALD ADVISERS, LLC 451,542$8,584,0000.36%
RTW INVESTMENTS, LP 503,266$9,567,0000.36%
EMERALD MUTUAL FUND ADVISERS TRUST 429,868$8,172,0000.33%
NEXT CENTURY GROWTH INVESTORS LLC 107,045$2,034,0000.26%
ELEMENT CAPITAL MANAGEMENT LLC 63,175$1,201,0000.26%
HAMILTON LANE ADVISORS LLC 19,364$368,0000.16%
Harbour Capital Advisors, LLC 20,900$397,0000.15%
View complete list of TRANSMEDICS GROUP INC shareholders